Skip to content

Integra LifeSciences IART Amortization of capitalized software and acquired intangible assets

Amortization of capitalized software and acquired intangible assets at other companies

Stryker logo
StrykerSYK
Medtronic logo
MedtronicMDT
CONMED logo
CONMEDCNMD
Boston Scientific logo
Boston ScientificBSX
Henry Schein logo
Henry ScheinHSIC
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC

Segments

By segment

See full
Specialty Surgery$0
Tissue Reconstruction$0

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Market cap$1.38B+53.4%
Enterprise value$3.12B+21.1%
P/S0.8×+0.3×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's amortization of capitalized software and acquired intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's amortization of capitalized software and acquired intangible assets?
Integra LifeSciences (IART) reported amortization of capitalized software and acquired intangible assets of $3.78M in Q1 2026.
How has Integra LifeSciences's amortization of capitalized software and acquired intangible assets changed year-over-year?
Integra LifeSciences's amortization of capitalized software and acquired intangible assets increased by 1.9% year-over-year, from $3.7M to $3.78M.
What is the long-term trend for Integra LifeSciences's amortization of capitalized software and acquired intangible assets?
Over 4 years (2021 to 2025), Integra LifeSciences's amortization of capitalized software and acquired intangible assets has grown at a -3.0% compound annual growth rate (CAGR), from $16.91M to $14.95M.